Cited by 301Statistical Methods and Bayesian InferenceStatistical Methods in Clinical TrialsPharmaceutical studies and practices

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets

Siddiqui, Ohidul, Hung, H. M. James, O'Neill, Robert·2009·Journal of Biopharmaceutical Statistics

DOI 10.1080/10543400802609797

Open this paper in CoChat — free account

Abstract

In recent years, the use of the last observation carried forward (LOCF) approach in imputing missing data in clinical trials has been greatly criticized, and several likelihood-based modeling approaches are proposed to analyze such incomplete data. One of the proposed likelihood-based methods is the Mixed-Effect Model Repeated Measure (MMRM) model. To compare the performance of LOCF and MMRM approaches in analyzing incomplete data, two extensive simulation studies are conducted, and the empirical bias and Type I error rates associated with estimators and tests of treatment effects under three missing data paradigms are evaluated. The simulation studies demonstrate that LOCF analysis can lead to substantial biases in estimators of treatment effects and can greatly inflate Type I error rates of the statistical tests, whereas MMRM analysis on the available data leads to estimators with comparatively small bias, and controls Type I error rates at a nominal level in the presence of missing completely at random (MCAR) or missing at random (MAR) and some possibility of missing not at random (MNAR) data. In a sensitivity analysis of 48 clinical trial datasets obtained from 25 New Drug Applications (NDA) submissions of neurological and psychiatric drug products, MMRM analysis appears to be a superior approach in controlling Type I error rates and minimizing biases, as compared to LOCF ANCOVA analysis. In the exploratory analyses of the datasets, no clear evidence of the presence of MNAR missingness is found.

Integrity signals

Registry

Crossref · 10.1080/10543400802609797

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,385
Inference and missing data
RUBIN, D. B. (1976) · Biometrika · doi:10.1093/biomet/63.3.581 · Cited by 9,925
Random-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Statistical Analysis with Missing Data
Little, R. J. A., & Rubin, D. B. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781119013563 · Cited by 8,473
Applied Longitudinal Analysis
Fitzmaurice, G. M., Laird, N. M., & Ware, J. H. (2011) · Wiley Series in Probability and Statistics · doi:10.1002/9781119513469 · Cited by 4,639
Linear Mixed Models for Longitudinal Data
Verbeke, G. (1997) · Lecture Notes in Statistics · doi:10.1007/978-1-4612-2294-1_3 · Cited by 3,506
Linear Mixed Models for Longitudinal Data
Molenberghs, G., & Verbeke, G. N. (2000) · Springer series in statistics · doi:10.1007/978-1-4419-0300-6 · Cited by 2,681
Modeling the Drop-Out Mechanism in Repeated-Measures Studies
Little, R. J. A. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476615 · Cited by 1,522
Informative Drop-Out in Longitudinal Data Analysis
Diggle, P. J., & Kenward, M. G. (1994) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.2307/2986113 · Cited by 1,472
Applied longitudinal analysis
(2004) · Choice Reviews Online · doi:10.5860/choice.42-2265 · Cited by 1,385

Show all 32 references

Sorted by citations

Strategy for intention to treat analysis in randomised trials with missing outcome data
White, I. R., Horton, N. J., Carpenter, J. R., statistics, R. I. M. A. S., & Pocock, S. (2011) · BMJ · doi:10.1136/bmj.d40 · Cited by 869
Final Results from PRIME: Randomized Phase III Study of Panitumumab with FOLFOX4 for First-Line Treatment of Metastatic Colorectal Cancer
Douillard, J. Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu141 · Cited by 606
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Moriarty, P. M., Thompson, P. D., Cannon, C. P., Guyton, J. R., Bergeron, J., Zieve, F. J., Bruckert, E., Jacobson, T. A., Kopecky, S. L., Baccara-Dinet, M. T., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.08.006 · Cited by 470
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe
Feldman, H. H., Doody, R. S., Kivipelto, M., Sparks, D. L., Waters, D. D., Jones, R. W., Schwam, E., Schindler, R., Hey-Hadavi, J., DeMicco, D. A., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d6476a · Cited by 438
An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418
Community-Implemented Trauma Therapy for Former Child Soldiers in Northern Uganda
Ertl, V., Pfeiffer, A., Schauer, E., Elbert, T. R., & Neuner, F. (2011) · JAMA · doi:10.1001/jama.2011.1060 · Cited by 343
Including all individuals is not enough: Lessons for intention-to-treat analysis
White, I. R., Carpenter, J. R., & Horton, N. J. (2012) · Clinical Trials · doi:10.1177/1740774512450098 · Cited by 310
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus
Ludvigsson, J., Krisky, D., Casas, R., Battelino, T., Castaño, L., Greening, J., Kordonouri, O., Otonkoski, T., Pozzilli, P., Robert, J.-J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1107096 · Cited by 340
Active self-correction and task-oriented exercises reduce spinal deformity and improve quality of life in subjects with mild adolescent idiopathic scoliosis. Results of a randomised controlled trial
Monticone, M., Ambrosini, E., Cazzaniga, D., Rocca, B., & Ferrante, S. (2014) · European Spine Journal · doi:10.1007/s00586-014-3241-y · Cited by 280
Benefits From Antidepressants: Synthesis of 6-Week Patient-Level Outcomes From Double-blind Placebo-Controlled Randomized Trials of Fluoxetine and Venlafaxine
Gibbons, R. D., Hur, K., Brown, C. H., Davis, J. M., & Mann, J. J. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2044 · Cited by 271
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure])
Feldman, T. E., Mauri, L., Kahwash, R., Litwin, S. E., Ricciardi, M. J., van der Harst, P., Pěnička, M., Fail, P. S., Kaye, D. M., Petrie, M. C., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.032094 · Cited by 274
Concurrent Naltrexone and Prolonged Exposure Therapy for Patients With Comorbid Alcohol Dependence and PTSD: A Randomized Clinical Trial
Foa, E. B., Yusko, D. A., McLean, C. P., Suvak, M. K., Bux, D. A., Oslin, D., O’Brien, C. P., Imms, P., Riggs, D. S., & Volpicelli, J. (2013) · JAMA · doi:10.1001/jama.2013.8268 · Cited by 267
The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders
Whiteley, P., Haracopos, D., Knivsberg, A.-M., Reichelt, K. L., Parlar, S., Jacobsen, J., Seim, A., Pedersen, L., Schondel, M., & Shattock, P. (2010) · Nutritional Neuroscience · doi:10.1179/147683010x12611460763922 · Cited by 266
A smartphone-based health care chatbot to promote self-management of chronic pain (SELMA): pilot randomized controlled trial
Hauser-Ulrich, S., Künzli, H., Meier-Peterhans, D., & Kowatsch, T. (2020) · JMIR mHealth and uHealth · doi:10.2196/15806 · Cited by 210
Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials.
Hamer, R. M., & Simpson, P. M. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040458 · Cited by 233
Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
Decramer, M., Anzueto, A., Kerwin, E., Kaelin, T., Richard, N., Crater, G., Tabberer, M. M., Harris, S. S., & Church, A. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70065-7 · Cited by 233
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
Deodhar, A. A., van der Heijde, D. M. F. M., Gensler, L. S., Kim, T., Maksymowych, W. P., Østergaard, M., Poddubnyy, D., Marzo‐Ortega, H., Bessette, L., Tomita, T., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32971-x · Cited by 218
Growth hormone plus childhood low-dose estrogen in Turner's syndrome
Ross, J. L., Quigley, C. A., Cao, D., Feuillan, P., Kowal, K., Chipman, J. J., & Cutler, G. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005669 · Cited by 212
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher
Ginsberg, H. N., Rader, D. J., Raal, F. J., Guyton, J. R., Baccara‐Dinet, M. T., Lorenzato, C., Pordy, R. C., & Stroes, E. S. G. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6685-y · Cited by 216
A Brief Intervention Reduces Hazardous and Harmful Drinking in Emergency Department Patients
D'Onofrio, G., Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Owens, P. H., Degutis, L. C., Busch, S. H., Bernstein, S. L., & O'Connor, P. G. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.02.006 · Cited by 207
Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
Geifman, N., Brinton, R. D., Kennedy, R. E., Schneider, L. S., & Butte, A. J. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0237-y · Cited by 191
Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial
Farnier, M., Jones, P. J. H., Severance, R., Averna, M. R., Steinhagen‐Thiessen, E., Colhoun, H. M., Du, Y. E., Hanotin, C., & Donahue, S. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.11.010 · Cited by 190
Missing Data in Alcohol Clinical Trials: A Comparison of Methods
Hallgren, K. A., & Witkiewitz, K. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12205 · Cited by 176
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
Bajbouj, M., Merkl, A., Schlaepfer, T. E., Frick, C., Zobel, A., Maier, W., O'Keane, V., Corcoran, C., Adolfsson, R., Trimble, M., et al. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181db8831 · Cited by 178
Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial
Wilkinson, D. G., Windfeld, K., & Colding‐Jørgensen, E. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70198-x · Cited by 164
A meta-analysis of randomized, placebo-controlled trials of vortioxetine for the treatment of major depressive disorder in adults
Thase, M. E., Mahableshwarkar, A. R., Dragheim, M., Loft, H., & Vieta, E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.007 · Cited by 165
A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)
Baldwin, D. S., Loft, H., & Dragheim, M. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.11.008 · Cited by 164
One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial
Shah, S. J., Feldman, T. E., Ricciardi, M. J., Kahwash, R., Lilly, S. M., Litwin, S. E., Nielsen, C., van der Harst, P., Hoendermis, E. S., Pěnička, M., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.2936 · Cited by 159
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Moriarty, P. M., Jacobson, T. A., Bruckert, E., Thompson, P. D., Guyton, J. R., Baccara-Dinet, M. T., & Gipe, D. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2014.09.007 · Cited by 154
A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
Block, G. A., Fishbane, S. N., Rodríguez, M., Smits, G., Shemesh, S., Pérgola, P. E., Wolf, M. S., & Chertow, G. M. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.10.014 · Cited by 154
Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial
Assael, B. M., Pressler, T., Bilton, D., Fayon, M. J., Fischer, R., Chiron, R., Larosa, M., Knoop, C., McElvaney, N. G., Lewis, S. A., et al. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.07.006 · Cited by 139
Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM‐INSULIN randomized trial
Leiter, L. A., Cariou, B., Müller‐Wieland, D., Colhoun, H. M., Prato, S. D., Tinahones, F. J., Ray, K. K., Bujas‐Bobanovic, M., Domenger, C., Mandel, J., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13114 · Cited by 138
Self-management intervention for chronic pain in older adults: A randomised controlled trial
Nicholas, M. K., Asghari, A., Blyth, F. M., Wood, B. M., Murray, R., McCabe, R., Brnabic, A., Beeston, L., Corbett, M., Sherrington, C., et al. (2013) · Pain · doi:10.1016/j.pain.2013.02.009 · Cited by 137
A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder
Mahableshwarkar, A. R., Jacobsen, P. L., & Chen, Y. (2012) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.761600 · Cited by 137
A Randomized Trial of a Web‐Based Intervention to Improve Migraine Self‐Management and Coping
Bromberg, J., Wood, M. E., Black, R. A., Surette, D. A., Zacharoff, K. L., & Chiauzzi, E. J. (2012) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.02031.x · Cited by 136
Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine
Lintzeris, N., Dunlop, A. J., Haber, P., Lubman, D. I., Graham, R., Hutchinson, S., Arunogiri, S., Hayes, V., Hjelmström, P., Svedberg, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.9041 · Cited by 129
Patient-reported outcomes from EMILIA, a randomized phase 3 study of trastuzumab emtansine (T-DM1) versus capecitabine and lapatinib in human epidermal growth factor receptor 2-positive locally advanced or metastatic breast cancer
Welslau, M., Diéras, V., Sohn, J., Hurvitz, S. A., Lalla, D., Fang, L., Althaus, B., Guardino, E., & Miles, D. (2014) · Cancer · doi:10.1002/cncr.28465 · Cited by 126
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: Concept and standards of the EARLYSTIM-study
Deuschl, G., Schüpbach, M. W. M., Knudsen, K., Pinsker, M. O., Cornu, P., Rau, J., Agid, Y., & Schade‐Brittinger, C. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.004 · Cited by 126
How to prove that your therapy is effective, even when it is not: a guideline
Cuijpers, P., & Cristea, I. A. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000864 · Cited by 122
Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial
Maleki-Yazdi, M. R., Kaelin, T., Richard, N., Zvarich, M. T., & Church, A. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.10.002 · Cited by 122
Zonisamide improves wearing‐off in Parkinson's disease: A randomized, double‐blind study
Murata, M., Hasegawa, K., Kanazawa, I., Fukasaka, J., Kochi, K., Shimazu, R., & The Japan Zonisamide on PD Study Group (2015) · Movement Disorders · doi:10.1002/mds.26286 · Cited by 121
Management of catastrophising and kinesiophobia improves rehabilitation after fusion for lumbar spondylolisthesis and stenosis. A randomised controlled trial
Monticone, M., Ferrante, S., Teli, M., Rocca, B., Foti, C., Lovi, A., & Brayda Bruno, M. (2014) · European Spine Journal · doi:10.1007/s00586-013-2889-z · Cited by 119
Inhaled Technosphere insulin compared with injected prandial insulin in type 1 diabetes: A randomized 24-week trial
Bode, B. W., McGill, J. B., Lorber, D. L., Gross, J. L., Chang, P.-C., Bregman, D. B., & for the Affinity 1 Study Group (2015) · Diabetes Care · doi:10.2337/dc15-0075 · Cited by 114
A systematic review of studies examining the rate of lung function decline in patients with cystic fibrosis
Harun, S. N., Wainwright, C. E., Klein, K., & Hennig, S. (2016) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2016.03.002 · Cited by 112
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial
TOMBAL, B. F., Fred Saad, C., Penson, D. F., Hussain, M., Sternberg, C. N., Morlock, R., Ramaswamy, K., Ivanescu, C., & Attard, G. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30898-2 · Cited by 107
A multidisciplinary rehabilitation programme improves disability, kinesiophobia and walking ability in subjects with chronic low back pain: results of a randomised controlled pilot study
Monticone, M., Ambrosini, E., Rocca, B., Magni, S., Brivio, F., & Ferrante, S. (2014) · European Spine Journal · doi:10.1007/s00586-014-3478-5 · Cited by 107
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
Kastelein, J. J. P., Robinson, J. G., Farnier, M., Krempf, M., Langslet, G., Lorenzato, C., Gipe, D. A., & Baccara‐Dinet, M. T. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6523-z · Cited by 102
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Nalbuphine ER Tablets for Uremic Pruritus
Mathur, V. S., Kumar, J., Crawford, P. W., Hait, H. I., Sciascia, T. R., & for the TR02 Study Investigators (2017) · American Journal of Nephrology · doi:10.1159/000484573 · Cited by 99
A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
Bentsen, H., Osnes, K., Refsum, H., Solberg, D. K., & Bøhmer, T. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.110 · Cited by 97
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studies
Koch, A., Pizzichini, E., Hamilton, A. L., Hart, L., Korducki, L., Salvo, M. D., & Paggiaro, P. (2014) · International Journal of COPD · doi:10.2147/copd.s62502 · Cited by 97
A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms
Baldwin, D. S., Florea, I., Jacobsen, P. L., Zhong, W., & Nomikos, G. G. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.07.015 · Cited by 95
Randomised, controlled trial of avocado–soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS study
Maheu, E., Cadet, C., Marty, M., Moyse, D., Kerloch, I., Coste, P., Dougados, M., Mazières, B., Spector, T. D., Halhol, H., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202485 · Cited by 86
Evaluation of performance of some enrichment designs dealing with high placebo response in psychiatric clinical trials
Chen, Y., Yang, Y., Hung, H., & Wang, S. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.04.006 · Cited by 84
Self-citation
Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
Tran, P., Skolnick, P., Czobor, P., Huang, N. Y., Bradshaw, M., McKinney, A., & Fava, M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.003 · Cited by 81
Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD
Nangaku, M., Kondo, K., Kokado, Y., Ueta, K., Kaneko, G., Tandai, T., Kawaguchi, Y., & Komatsu, Y. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020091311 · Cited by 85
Impact of enzalutamide on quality of life in men with metastatic castration-resistant prostate cancer after chemotherapy: additional analyses from the AFFIRM randomized clinical trial
Cella, D., Ivanescu, C., Holmstrom, S., Bui, C. N., Spalding, J., & Fizazi, K. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu510 · Cited by 79
Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism
Vokes, T., Mannstadt, M., Levine, M. A., Clarke, B. L., Lakatos, P., Chen, K. S., Piccolo, R. S., Krasner, A. S., Shoback, D., & Bilezikian, J. P. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01471 · Cited by 79
All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis
Ogura, T., Azuma, A., Inoue, Y., Taniguchi, H., Chida, K., Bando, M., Niimi, Y., Kakutani, S., Suga, M., Sugiyama, Y., et al. (2015) · Respiratory Investigation · doi:10.1016/j.resinv.2015.06.001 · Cited by 76
Spinal cord stimulation effects on myocardial ischemia, infarct size, ventricular arrhythmia, and noninvasive electrophysiology in a porcine ischemia–reperfusion model
Odenstedt, J., Linderoth, B., Bergfeldt, L., Ekre, O., Grip, L., Mannheimer, C., & Andréll, P. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.01.029 · Cited by 76
Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial
Savitz, J. B., Preskorn, S., Teague, T. K., Drevets, D. A., Yates, W. R., & Drevets, W. (2012) · BMJ Open · doi:10.1136/bmjopen-2011-000643 · Cited by 73
Challenges in detecting disease modification in Parkinson's disease clinical trials
Athauda, D. S., & Foltynie, T. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.07.019 · Cited by 73
A 1-year videoconferencing-based psychoeducational group intervention following bariatric surgery: results of a randomized controlled study
Wild, B., Hünnemeyer, K., Sauer, H., Hain, B., Mack, I., Schellberg, D., Müller-Stich, B. P., Weiner, R., Meile, T., Rudofsky, G., et al. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.05.018 · Cited by 70
On Efficiency of Constrained Longitudinal Data Analysis Versus Longitudinal Analysis of Covariance
Lu, K. (2010) · Biometrics · doi:10.1111/j.1541-0420.2009.01332.x · Cited by 69
Cognitive exposure versus avoidance in patients with chronic pain: Adherence matters
Nicholas, M. K., Asghari̇, A., Sharpe, L., Brnabic, A. J. M., Wood, B. M., Overton, S., Tonkin, L., Sousa, M. D., Finniss, D. G., Beeston, L., et al. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00383.x · Cited by 70
Missing data treatments in intervention studies: What was, what is, and what should be
Rioux, C., & Little, T. D. (2019) · International Journal of Behavioral Development · doi:10.1177/0165025419880609 · Cited by 73
Publication Bias, with a Focus on Psychiatry: Causes and Solutions
Turner, E. H. (2013) · CNS Drugs · doi:10.1007/s40263-013-0067-9 · Cited by 65
Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
Samtani, M. N., Raghavan, N., Novak, G., Nandy, P., & Narayan, V. A. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62323 · Cited by 65
Efficacy and safety of vadadustat compared with darbepoetin alfa in Japanese anemic patients on hemodialysis: a Phase 3, multicenter, randomized, double-blind study
Nangaku, M., Kondo, K., Ueta, K., Kokado, Y., Kaneko, G., Matsuda, H., Kawaguchi, Y., & Komatsu, Y. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab055 · Cited by 65
Evaluation of a web-based acceptance and commitment therapy program for women with trauma-related problems: A pilot study
Fiorillo, D., McLean, C., Pistorello, J., Hayes, S. C., & Follette, V. M. (2017) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2016.11.003 · Cited by 61
Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies
Siler, T. M., Kerwin, E., Singletary, K., Brooks, J., & Church, A. (2015) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2015.1034256 · Cited by 64
MMRM versus MI in Dealing with Missing Data—A Comparison Based on 25 NDA Data Sets
Siddiqui, O. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543401003777995 · Cited by 63
Self-citation
Combination of Niacin and Fenofibrate with Lifestyle Changes Improves Dyslipidemia and Hypoadiponectinemia in HIV Patients on Antiretroviral Therapy: Results of “Heart Positive,” a Randomized, Controlled Trial
Balasubramanyam, A., Coraza, I., Smith, E. O., Scott, L. W., Patel, P., Iyer, D., Taylor, A. A., Giordano, T. P., Sekhar, R. V., Clark, P., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-3067 · Cited by 63
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 4: Unmet Needs in the Treatment of Bipolar Disorder and Recommendations for Future Research
Fountoulakis, K. Ν., Vieta, E., Young, A. H., Yatham, L. N., Grunze, H., Blier, P., Moeller, H. J., & Kasper, S. F. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw072 · Cited by 63
A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder
Wilens, T. E., Robertson, B., Sikirica, V., Harper, L., Young, J. L., Bloomfield, R., Lyne, A., Rynkowski, G., & Cutler, A. J. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.08.016 · Cited by 68
Parkinsonism and Related Disorders
Slow, E., & Lang, A. E. (2019) · DeckerMed Transitional Year Weekly Curriculum™ · doi:10.2310/tywc.1178 · Cited by 62
Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trials
Colhoun, H. M., Robinson, J. G., Farnier, M., Cariou, B., Blom, D. J., Kereiakes, D. J., Lorenzato, C., Pordy, R. C., & Chaudhari, U. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-121 · Cited by 61
Corticosteroid-free Kidney Transplantation Improves Growth
Webb, N. J. A., Douglas, S. E., Rajai, A., Roberts, S. A., Grenda, R., Marks, S. D., Watson, A. R., Fitzpatrick, M. M., Vondrák, K., Maxwell, H., et al. (2015) · Transplantation · doi:10.1097/tp.0000000000000498 · Cited by 61
Be a Mom’s Efficacy in Enhancing Positive Mental Health among Postpartum Women Presenting Low Risk for Postpartum Depression: Results from a Pilot Randomized Trial
Monteiro, F., Pereira, M., Canavarro, M. C., & Fonseca, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17134679 · Cited by 58
“All available data are used to obtain parameter estimates with small bias in the presence of data missing completely at random or missing at random [63].”
Method
Expression of Concern: Group‐based task‐oriented exercises aimed at managing kinesiophobia improved disability in chronic low back pain
Monticone, M., Ambrosini, E., Rocca, B., Cazzaniga, D., Liquori, V., & Foti, C. (2016) · European Journal of Pain · doi:10.1002/ejp.756 · Cited by 80
Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
Bennett, L., Zhao, Z., Barber, B. R., Zhou, X., Peeters, M., Zhang, J., Xu, F., Wiezorek, J. S., & Douillard, J.-Y. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.409 · Cited by 59
The Placebo Effect in Clinical Trials for Alcohol Dependence: An Exploratory Analysis of 51 Naltrexone and Acamprosate Studies
Litten, R. Z., Castle, I. P., Falk, D. E., Ryan, M., Fertig, J. B., Chen, C. M., & Yi, H. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12197 · Cited by 59
Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day
Berlin, I., Chen, H., & Covey, L. S. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03109.x · Cited by 56
Treatment of Recent-Onset Type 1 Diabetic Patients With DiaPep277: Results of a Double-Blind, Placebo-Controlled, Randomized Phase 3 Trial
Raz, I., Ziegler, A. G., Linn, T., Schernthaner, G., Bonńici, F., Distiller, L. A., Giordano, C. S. D. S., Giorgino, F., de Vries, L., Mauricio, D., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1391 · Cited by 57
Retracted
Hylan G-F 20 Improves Hip Osteoarthritis: A Prospective, Randomized Study
Spitzer, A. I., Bockow, B. I., Brander, V. A., Yates, J. W., MacCarter, D. K., Gudger, G. K., Haller, S., Lake, S. L., & Magilavy, D. B. (2010) · The Physician and Sportsmedicine · doi:10.3810/psm.2010.06.1781 · Cited by 57
Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder
Soares, C. N., Thase, M. E., Clayton, A. H., Guico‐Pabia, C. J., Focht, K., Jiang, Q. L., Kornstein, S. G., Ninan, P. T., Kane, C. P., & Cohen, L. S. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181d88962 · Cited by 57
Comparisons of Analysis Methods for Proof‐of‐Concept Trials
Karlsson, K. E., Vong, C., Bergstrand, M., Jonsson, E. N., & Karlsson, M. (2013) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2012.24 · Cited by 55
Long-term outcomes from training in self-management of chronic pain in an elderly population: a randomized controlled trial
Nicholas, M. K., Asghari, A., Blyth, F., Wood, B. M., Murray, R., McCabe, R., Brnabic, A. J. M., Beeston, L., Corbett, M., Sherrington, C., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000729 · Cited by 56
Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D
Adkins, D. E., Clark, S. L., Åberg, K. A., Hettema, J. M., Bukszár, J., McClay, J. L., de Souza, R. P., & van den Oord, E. J. C. G. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.57 · Cited by 52
Effects of CYP2C19 allelic variants on inhibition of platelet aggregation and major adverse cardiovascular events in Japanese patients with acute coronary syndrome: The PRASFIT-ACS study
Ogawa, H., Isshiki, T., Kimura, T., Yokoi, H., Nanto, S., Takayama, M., Kitagawa, K., Nishikawa, M., Miyazaki, S., Ikeda, Y., et al. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.07.019 · Cited by 51
Adding a smartphone app to internet-based self-help for social anxiety: A randomized controlled trial
Boettcher, J., Magnusson, K., Marklund, A., Berglund, E., Blomdahl, R., Braun, U., Delin, L., Lundén, C., Sjöblom, K., Sommer, D., et al. (2018) · Computers in Human Behavior · doi:10.1016/j.chb.2018.04.052 · Cited by 47
Handling Missing Data With Multilevel Structural Equation Modeling and Full Information Maximum Likelihood Techniques
Schminkey, D. L., von Oertzen, T., & Bullock, L. (2016) · Research in Nursing & Health · doi:10.1002/nur.21724 · Cited by 48
Cognitive behaviour therapy via the internet for depression: A useful strategy to reduce suicidal ideation
Mewton, L. R., & Andrews, G. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.08.038 · Cited by 54
Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial
Mayer, J. S., Hees, K., Medda, J., Grimm, O., Asherson, P., Bellina, M., Colla, M., Ibáñez, P., Koch, E., Martinez-Nicolas, A., et al. (2018) · Trials · doi:10.1186/s13063-017-2426-1 · Cited by 48
Adults with idiopathic scoliosis improve disability after motor and cognitive rehabilitation: results of a randomised controlled trial
Monticone, M., Ambrosini, E., Cazzaniga, D., Rocca, B., Motta, L., Cerri, C., Brayda‐Bruno, M., & Lovi, A. (2016) · European Spine Journal · doi:10.1007/s00586-016-4528-y · Cited by 48
Is there a genuine placebo effect in acute depression treatments? A reassessment of regression to the mean and spontaneous remission
Hengartner, M. P. (2019) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2019-111161 · Cited by 48
Efficacy and Safety of Dextromethorphan/Quinidine at Two Dosage Levels for Diabetic Neuropathic Pain: A Double-Blind, Placebo-Controlled, Multicenter Study
Shaibani, A. I., Pope, L. E., Thisted, R. A., & Hepner, A. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01316.x · Cited by 48
Acupuncture for chronic fatigue syndrome and idiopathic chronic fatigue: a multicenter, nonblinded, randomized controlled trial
Kim, J., Seo, B.-K., Choi, J.-B., Kim, H.-J., Kim, T., Lee, M.-H., Kang, K., Kim, J., Shin, K.-M., Lee, S., et al. (2015) · Trials · doi:10.1186/s13063-015-0857-0 · Cited by 47
Missing Data: Turning Guidance Into Action
Mallinckrodt, C. H., Roger, J., Chuang‐Stein, C., Molenberghs, G., Lane, P. W., O’Kelly, M., Ratitch, B., Xu, L., Gilbert, S., Mehrotra, D. V., et al. (2013) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2013.848822 · Cited by 44
Missing Data Handling in Chronic Pain Trials
Kim, Y. (2011) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2011.550112 · Cited by 46
Efficacy and Safety of Alirocumab as Add‐on Therapy in High–Cardiovascular‐Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies
Robinson, J. G., Colhoun, H. M., Bays, H. E., Jones, P. H., Du, Y. E., Hanotin, C., & Donahue, S. (2014) · Clinical Cardiology · doi:10.1002/clc.22327 · Cited by 45

Authors: Siddiqui, O., Hung, H. M. J., & O'Neill, R.
Affiliations: United States Food and Drug Administration (US)
a Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland, USA
Corresponding author: Siddiqui, Ohidul
ORCID: Hung, H. M. James
Venue: Journal of Biopharmaceutical Statistics
Publisher: Informa UK Limited
Published: 2009-02-12
Volume: 19
Issue: 2
Pages: 227-246
ISSN: 1054-3406 (ISSN-L)
1520-5711
DOI: 10.1080/10543400802609797
OpenAlex: W2129152730
Cited by: 301
References: 32
Citations by year: 2026: 5 · 2025: 8 · 2024: 7 · 2023: 15 · 2022: 10 · 2021: 12 · 2020: 18 · 2019: 14 · 2018: 16 · 2017: 23 · 2016: 22 · 2015: 25 · 2014: 32 · 2013: 31 · 2012: 20
FWCI: 17.15
Type: journal article
Language: en
Open access: closed
Locations: Journal of Biopharmaceutical Statistics (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords: last observation carried forward, missing data imputation, clinical trials, type I error rate, estimation bias, missing completely at random, missing at random, missing not at random, new drug applications, neurological drugs, psychiatric medication, covariance analysis
MeSH terms: Algorithms, Clinical Trials as Topic, Computer Simulation, Data Interpretation, Statistical, Humans, Longitudinal Studies, Psychotropic Drugs, Regression Analysis, United States, United States Food and Drug Administration, Reproducibility of Results, Models, Statistical, Bias, Likelihood Functions, Least-Squares Analysis, Databases, Factual

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks